Alopecia Areata: Current Situation and Perspectives

    October 2017 in “ Archivos Argentinos De Pediatria
    Karina Janett Juárez-Rendón, Gildardo Rivera, Miguel Ángel Reyes-López, José Elías García-Ortiz, Virgilio Bocanegra-García, Iliana Guardiola-Avila, María L Altamirano-García
    New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This review discusses the clinical characteristics, diagnosis, and treatment of alopecia areata, exploring potential environmental, immunological, and genetic factors involved in its development, but reports no new research findings.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The 2017 document reviews Alopecia Areata (AA), a complex autoimmune hair loss condition affecting 1-2% of the population without gender preference. It outlines the classifications of AA, the hair follicle growth cycle, and potential environmental triggers such as stress and infections. The condition is associated with autoimmune diseases and involves T lymphocyte infiltration into hair follicles. AA is polygenic with several susceptibility genes identified. Diagnosis typically involves clinical and sometimes histological examination, while treatment options like immunotherapy and corticosteroids vary in effectiveness, with no universally accepted treatment and unpredictable prognosis. Severe cases, particularly in children before puberty, have a grim outlook with less than a 10% chance of full recovery. The psychological impact of AA is significant, requiring medical and psychological support. The document calls for new treatments targeting genes related to autoimmune processes and hair follicle function due to the current treatments' limitations in preventing relapse and side effects.
    Discuss this study in the Community →